Zymeworks to Present at Stifel 2019 Healthcare Conference
04 Novembro 2019 - 6:15PM
Business Wire
Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical
company developing multifunctional therapeutics, today announced
that management will present at the upcoming Stifel 2019 Healthcare
Conference taking place November 19-20, 2019 in New York, NY.
The Company’s presentation will be on Tuesday, November 19, 2019
at 8:00 a.m. ET.
Interested parties can access a live webcast of the presentation
via a link from Zymeworks’ website at
http://ir.zymeworks.com/events-and-presentations, which will also
host a recorded replay available afterwards.
About Zymeworks Inc.
Zymeworks is a clinical-stage biopharmaceutical company
dedicated to the development of next-generation multifunctional
biotherapeutics. Zymeworks’ suite of therapeutic platforms and its
fully integrated drug development engine enable precise engineering
of highly differentiated product candidates. Zymeworks’ lead
clinical candidate, ZW25, is a novel Azymetric™ bispecific antibody
currently in Phase 2 clinical development. Zymeworks’ second
clinical candidate, ZW49, is a bispecific antibody-drug conjugate
currently in Phase 1 clinical development and combines the unique
design and antibody framework of ZW25 with Zymeworks’ proprietary
ZymeLink™ cytotoxic payload. Zymeworks is also advancing a deep
preclinical pipeline in immuno-oncology and other therapeutic
areas. In addition, its therapeutic platforms are being leveraged
through strategic partnerships with nine biopharmaceutical
companies. For more information, visit www.zymeworks.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191104005136/en/
Zymeworks Inc.
Investor Inquiries: Ryan Dercho, Ph.D. (604) 678-1388
ir@zymeworks.com
Tiffany Tolmie (604) 678-1388 ir@zymeworks.com
Media Inquiries: Kavita Shah, Ph.D. (604) 678-1388
info@zymeworks.com
Zymeworks (NYSE:ZYME)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Zymeworks (NYSE:ZYME)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024